Kera Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.29M Sell
19,037
-221
-1% -$25.5K 0.28% 53
2025
Q4
$2.12M Buy
19,258
+1,604
+9% +$151K 0.26% 57
2025
Q3
$1.48M Buy
17,654
+9,382
+113% +$773K 0.22% 63
2025
Q2
$655K Buy
8,272
+4,420
+115% +$351K 0.13% 69
2025
Q1
$346K Buy
3,852
+282
+8% +$26.3K 0.1% 77
2024
Q4
$355K Buy
+3,570
New +$368K 0.1% 72

Other funds holding MRK

Kera Capital Partners's MRK Position: Q1 2026 in Review

Kera Capital Partners reduced its Merck (MRK) stake by 1.1% in Q1 2026, selling an estimated $25.5K and leaving 19,037 shares worth $2.29M. The position accounts for 0.28% of the portfolio, ranked #53.

Kera Capital Partners first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Kera Capital Partners held 19,037 shares of Merck worth $2.29M as of Q1 2026.
  • Kera Capital Partners sold 221 Merck shares in Q1 2026, an estimated $25.5K.
  • Merck made up 0.28% of Kera Capital Partners's portfolio in Q1 2026, its #53 holding.
  • Kera Capital Partners first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Kera Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.